["Blind" trans-bronchial biopsy of the lung in the diagnosis of interstitial lung diseases].
The aim of the study was to assess the diagnostic effectiveness and safety of "blind" transbronchial lung biopsy (B-TBLB) in interstitial lung diseases (ILD). The diagnostic yield of B-TBLB performed in 44 patients was compared with similar yield of classical TBLB carried out in 25 patients. A diagnosis was made by B-TBLB in 29 patients (65.9%) and 14 (56%) by classical TBLB. Most often sarcoidosis, allergic alveolitis, pneumoconioses were found. Side effects were seen in both groups: in the B-TBLB group in 11.4%, in patients that underwent classical TBLB in 32%. It seems that blind transbronchial lung biopsy is a safe, effective and acceptable diagnostical method of interstitial lung disorders.